Association Between Apolipoprotein E Gene Polymorphism and Gallstone Disease in Sulaymaniyah Governorate Women
DOI:
https://doi.org/10.31351/vol33iss3pp80-88Keywords:
Apolipoprotein E, Gallstone disease, polymorphisms, APOE, GenotypeAbstract
Gallstone disease (GSD) is a worldwide problem; the frequency of GSD varies greatly amongst different ethnic groups, possibly due to environmental and genetic factors. One circulating lipoprotein involved in lipid metabolism is apolipoprotein E (APOE). The APOE gene is polymorphic, has three distinct alleles, APOE2, APOE3, and APOE4. The an APOE polymorphism is linked to a variety of diseases, including Alzheimer's and type-two diabetes, so this study aimed to assess the relationship among various APOE genotypes and alleles with gallstone cases in Iraqi Kurdish women. The present case-control study involved 81 cases with laparoscopic cholecystectomy for gallstone disease and 80 healthy women without GSD. Genomic DNA samples were taken from blood to find the genotype of APOE using allele-specific sequence-primers and a method based on polymerase chain reaction (PCR). lipid profiles were examined using an automated biochemical analyzer. SPSS and GraphPad Prism 9.1.1 software were used to conduct the statistical analysis. No significant relationships were found between healthy people and GSD patients in genotype and allele frequencies. However, the genotype for E3/E4 and the APOE4 allele in GSD patients were higher than the controls (9.88% vs. 5.0% and 4.94% vs. 2.5%, respectively; P <0.05) but statistically nonsignificant. serum levels of cholesterol, low-density lipoproteins, and very low-density lipoproteins were higher, and the levels of serum high-density lipoprotein was lower than controls. These findings revealed no connection between the examined polymorphisms and gallstone cases. Additionally, it was demonstrated that gallstone disease and lipid parameters had a favorable relationship.
Keywords: Apolipoprotein E, APOE, Gallstone disease, Genotype, Polymorphisms.
Received 12/6/2023
Accepted 3/9/2023
Published 15/9/2024
References
Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34(2):81-9.
Li L, Qiao X, Wang X, Liu D, Xue Q, Han L, et al. The association between apolipoprotein E and gallstone disease: an updated meta-analysis. BMC Med Genet. 2019;20(1):109-17.
Shabanzadeh DM, Skaaby T, Sørensen LT, Eugen-Olsen J, Jørgensen T. Metabolic biomarkers and gallstone disease - a population-based study. Scand J Gastroenterol. 2017;52(11):1270-7.
Ahmed F, Baloch Q, Memon ZA, Ali I. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann. Med. Surg.. 2017;17:7-13.
Zhu Q, Sun X, Ji X, Zhu L, Xu J, Wang C, et al. The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. Sci Rep. 2016;6(1):29937-45.
Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, et al. Factors Influencing Gallstone Formation: A Review of the Literature. Biomolecules. 2022;12(4):550-62.
Raj U, Kumar A, Mandial V. Biochemical analysis of gallstones. Int J Surg. 2022;6(1):219-25.
Thamer SJ. Pathogenesis, Diagnosis and Treatment of Gallstone Disease: A Brief Review. BCS. 2022;1(2):70-7.
Abdullah BH, Jassam SA, Hadi WA, Hameed B. Gallbladder stone formation in Iraqi patients is associated with bacterial infection and HLA class II-DRB1 antigens. Indian J Pathol Microbiol. 2020;63(4):570-4.
Al-Amedy OS, Saido GA, Hussein MR. Assessment of the Women’S Knowledge Regarding Cholelithiasis Diseases in Duhok City. Mosul j nurs. 2020;8(1):42-59.
Xue P, Niu WQ, Jiang ZY, Zheng MH, Fei J. A meta-analysis of apolipoprotein E gene ε2/ε3/ε4 polymorphism for gallbladder stone disease. PLoS One. 2012;7(9):e45849.
Abou Khalil Y, Rabès J-P, Boileau C, Varret M. APOE gene variants in primary dyslipidemia. Atherosclerosis. 2021;328:11-22.
Al-Jaf SMA. Frequencies of Apolipoprotein E polymorphism in Iraqi Kurdish population. Meta Gene. 2021;28:100867-71.
Benyahya F, Barakat A, Ghailani N, Bennani M. Apolipoprotein E polymorphism in the population of northern Morocco: frequency and effect on lipid parameters. Pan Afr Med J. 2013;15:157-65.
Zhao N, Liu CC, Qiao W, Bu G. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease. Biol Psychiatry. 2018;83(4):347-57.
Pleva L, Kusnierova P, Plevova P, Hilscherova S, Karpisek M, Zapletalova J, et al. The APOE ɛ2 allele is associated with increased plasma apolipoprotein E levels in patients with coronary artery disease. Cor Vasa. 2017;59(3):e235-e9.
Huebbe P, Rimbach G. Evolution of human apolipoprotein E (APOE) isoforms: Gene structure, protein function and interaction with dietary factors. Ageing Res Rev. 2017;37:146-61.
Yamazaki Y, Painter MM, Bu G, Kanekiyo T. Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence. CNS Drugs. 2016;30(9):773-89.
Ashiq S, Ashiq K. The association of apolipoprotein-E (APOE) gene polymorphisms with coronary artery disease: a systematic review and meta-analysis. Egypt J Med Hum Genet. 2021;22(1):16-23.
Yu J-T, Tan L, Hardy J. Apolipoprotein E in Alzheimer's disease: an update. Annu Rev Neurosci. 2014;37:79-100.
Liu S, Liu J, Weng R, Gu X, Zhong Z. Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes. BMC Cardiovasc Disord. 2019;19(1):213-18.
Wang C, Zhang M, Garcia Jr G, Tian E, Cui Q, Chen X, et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell. 2021;28(2):331-42.
Al-Jaf SM, Niranji SS, Ali HN, Mohammed OA. Association of Apolipoprotein e polymorphism with SARS-CoV-2 infection. Infect Genet Evol. 2021;95:105043-47.
Zhang M, Mao M, Zhang C, Hu F, Cui P, Li G, et al. Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis. Lipids Health Dis. 2022;21(1):26-37.
Lammert F, Gurusamy K, Ko CW, Miquel J-F, Méndez-Sánchez N, Portincasa P, et al. Gallstones. Nat Rev Dis Primers. 2016;2(1):1-17.
Nie C, Li Z, Yang T, Zhong J, Liu Q, Mi F, et al. Associations of long-term exposure to particulate matter with gallstone risks in Chinese adults: A large cross-sectional study. Ecotoxicol Environ Saf. 2023;252:114644-51.
Pantelidis P, Lambert-Hammill M, Wierzbicki AS. Simple sequence-specific-primer-PCR method to identify the three main apolipoprotein E haplotypes. Clin Chem. 2003;49(11):1945-8.
Niranji SS. Genetic polymorphism of toll-like receptor 4 Thr399Ile variant in Iraqi Kurdish population: sulaymaniyah province. Passer j basic appl sci. 2020;2(1):32-6.
Sanchez-Cuen J, Aguilar-Medina M, Arambula-Meraz E, Romero-Navarro J, Granados J, Sicairos-Medina L, et al. ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease. World J Gastroenterol. 2010;16(37):4685-90.
Ko CW, Beresford SA, Alderman B, Jarvik GP, Schulte SJ, Calhoun B, et al. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology. 2000;31(1):18-23.
Dixit M, Choudhuri G, Mittal B. Association of APOE-C1 gene cluster polymorphisms with gallstone disease. Dig Liver Dis. 2006;38(6):397-403.
Jiang Z-Y, Han T-Q, Suo G-J, Feng D-X, Chen S, Cai X-X, et al. Polymorphisms at cholesterol 7α-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol. 2004;10(10):1508-12.
Martinez-Lopez E, Curiel-Lopez F, Hernandez-Nazara A, Moreno-Luna LE, Ramos-Marquez ME, Roman S, et al. Influence of ApoE and FABP2 polymorphisms and environmental factors in the susceptibility to gallstone disease. Ann Hepatol. 2015;14(4):515-23.
Shabanzadeh DM, Skaaby T, Sørensen LT, Eugen-Olsen J, Jørgensen T. Metabolic biomarkers and gallstone disease - a population-based study. Scand J Gastroenterol. 2017;52(11):1270-7.
Kervinen K, Savolainen MJ, Salokannel J, Hynninen A, Heikkinen J, Ehnholm C, et al. Apolipoprotein E and B polymorphisms-longevity factors assessed in nonagenarians. Atherosclerosis. 1994;105(1):89-95.
Juvonen T, Kervinen K, Kairaluoma MI, Lajunen LH, Kesäniemi YA. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology. 1993;104(6):1806-13.
Bertomeu A, Ros E, Zambon D, Vela M, Perez-Ayuso RM, Targarona E, et al. Apolipoprotein E polymorphism and gallstones. Am J Dig Dis. 1996;111(6):1603-10.
Stender S, Frikke-Schmidt R, Benn M, Nordestgaard BG, Tybjærg-Hansen A. Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses. J Hepatol. 2013;58(1):126-33.
Ho Y-Y, Al-Haideri M, Mazzone T, Vogel T, Presley JF, Sturley SL, et al. Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles. Biochemistry. 2000;39(16):4746-54.
Saldanha P, Suneja P, Raj A. Serum lipid profile in patients with cholesterol containing gallstones: A study from South India. MGM j med sci. 2020;7(2):63-7.
Saha GC, Dhali DK, Rashid MSU, Dey D, Al Mamun MH, Chhanda CS. Cholelithiasis and its Relationship with Serum Lipids in a Tertiary Care Hospital of Rajshahi. Sir Salimullah Medical College Journal. 2021;29(2):95-9.
Kwon O-S, Kim Y-K, Her KH, Kim HJ, Lee SD. Physical activity can reduce the prevalence of gallstone disease among males: An observational study. Medicine. 2020;99(26):e20763.
Gu Q, Zhou G, Xu T. Risk factors for gallstone disease in Shanghai: An observational study. Medicine (Baltimore). 2020;99(3):e18754.
Hayat S, Hassan Z, Changazi SH, Zahra A, Noman M, Zain Ul Abdin M, et al. Comparative analysis of serum lipid profiles in patients with and without gallstones: A prospective cross-sectional study. Ann Med Surg. 2019;42:11-3.
Wang J, Shen S, Wang B, Ni X, Liu H, Ni X, et al. Serum lipid levels are the risk factors of gallbladder stones: a population-based study in China. Lipids Health Dis. 2020;19(1):50-5.
Balakrishnan G, Iqbal T, Uppinakudru G, Fernandes R, Bangera S, Dutt RA. The impact of lifestyle stressors, menstrual pattern, and cardiometabolic risk factors on young females with cholelithiasis. J Educ Health Promot. 2022;11:255.
Fischer S, Dolu MH, Zündt B, Meyer G, Geisler S, Jüngst D. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur J Clin Invest. 2001;31(9):789-95.
Weerakoon HTW, Ranasinghe S, Navaratne A, Sivakanesan R, Galketiya KB, Rosairo SN. Serum lipid concentrations in patients with cholesterol and pigment gallstones. J BMC Research. 2014;7(2):548-53.
A PediatriaTudorache IF, Trusca VG, Gafencu AV. Apolipoprotein E-a multifunctional protein with implications in various pathologies as a result of its structural features. Comput Struct Biotechnol J. 2017;15:359-65.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal of Pharmaceutical Sciences( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
